Position in NVO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$39,310
+$13,218 QoQ
Shares Held
820
+15.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,137
of 1,348 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Medallion Wealth Advisors, LLC holds $1,677,767 across 13 Drug Manufacturers - General names. NVO ranks #7 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
1,877 | $472,328 | |
| 2 | AMGN |
Amgen Inc
|
1,141 | $413,178 | |
| 3 | PFE |
Pfizer Inc
|
15,343 | $369,459 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
955 | $120,654 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
2,084 | $120,080 | |
| 6 | NVS |
Novartis AG
|
265 | $41,530 | |
| 7 | NVO |
Novo Nordisk A S
This page
|
820 | $39,310 | |
| 8 | MRK |
Merck & Co., Inc.
|
258 | $33,153 |
All Filings in NVO
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $39,310 | 820 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $26,092 | 710 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $13,025 | 256 | Shares | Sole | 2026-04-24 | |
| 2025-09-30 | $15,314 | 276 | Shares | Sole | 2026-04-24 | |
| 2025-06-30 | $24,018 | 348 | Shares | Sole | 2026-04-24 | |
| 2025-03-31 | $33,884 | 488 | Shares | Sole | 2026-04-24 | |
| 2024-12-31 | $27,181 | 316 | Shares | Sole | 2026-04-24 | |
| No filing history on record for this holder in this stock. | ||||||